Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Brain and Central Nervous System Tumors
Location: Hartford, Connecticut
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
Location: Hartford, Connecticut
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Conditions: Sarcoma
Location: Hartford, Connecticut
- Study of Late-Occurring Complications in Childhood Cancer Survivors
Conditions: Cancer
Location: Hartford, Connecticut
- Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastom
Conditions: Brain and Central Nervous System Tumors
Location: Hartford, Connecticut
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: Farmington, Connecticut
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: Hartford, Connecticut
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: New Britain, Connecticut
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Norwich, Connecticut
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Conditions: Sarcoma
Location: Hartford, Connecticut
- A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treate
Conditions: Mucopolysaccharidosis I - Hurler's Syndrome - Hurler-Scheie Syndrome - Scheie's Syndrome
Location: Hartford, Connecticut
- Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension
Conditions: Cardiovascular Diseases - Heart Diseases - Hypertension
Location: Storrs, Connecticut
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Hartford, Connecticut
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Hartford, Connecticut
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Middletown, Connecticut
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: New Britain, Connecticut
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Norwich, Connecticut
- Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome
Conditions: Turner Syndrome
Location: Hartford, Connecticut
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Hartford, Connecticut
- Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Conditions: Head and Neck Cancer - Radiation Toxicity
Location: Hartford, Connecticut
- Stepped Care for Treating Obsessive-Compulsive Disorder
Conditions: Obsessive-Compulsive Disorder
Location: Hartford, Connecticut
- Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Hartford, Connecticut
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Conditions: Kidney Cancer
Location: Hartford, Connecticut
- Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surge
Conditions: Kidney Cancer
Location: Hartford, Connecticut
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Conditions: Sarcoma
Location: Hartford, Connecticut
- Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Hartford, Connecticut
- Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Pati
Conditions: Cervical Cancer - Endometrial Cancer
Location: New Britain, Connecticut
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
Location: Hartford, Connecticut
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Hartford, Connecticut
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: Hartford, Connecticut
- Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
Conditions: Ototoxicity - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Hartford, Connecticut
- Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Hartford, Connecticut
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Hartford, Connecticut
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Hartford, Connecticut
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: New Britain, Connecticut
- Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Conditions: Neuroblastoma
Location: Hartford, Connecticut
- Examining Heart Attacks in Young Women
Conditions: Myocardial Infarction
Location: Hartford, Connecticut
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Middletown, Connecticut
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: New Britain, Connecticut
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Hartford, Connecticut
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Hartford, Connecticut
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Conditions: Schizophrenia - Bipolar
Location: Hartford, Connecticut
- Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- ChemoFx® PRO - A Post-Market Data Collection Study
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer - Uterine Neoplasms - Endometrial Cancer - Vaginal Cancer - Vulvar Cancer - Cervical Cancer - Lung Cancer - Carcinoid Tumor of Lung - Sarcoma of Lung - Mesothelioma - Colorectal Cancer
Location: Hartford, Connecticut
- ChemoFx® PRO - A Post-Market Data Collection Study
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer - Uterine Neoplasms - Endometrial Cancer - Vaginal Cancer - Vulvar Cancer - Cervical Cancer - Lung Cancer - Carcinoid Tumor of Lung - Sarcoma of Lung - Mesothelioma - Colorectal Cancer
Location: New Haven, Connecticut
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Middletown, Connecticut
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: New Britain, Connecticut
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Hartford, Connecticut
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Middletown, Connecticut
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: New Britain, Connecticut
- Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Hartford, Connecticut
- Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Middletown, Connecticut
- TODAY Genetics Study
Conditions: Type 2 Diabetes
Location: Hartford, Connecticut
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Hartford, Connecticut
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Hartford, Connecticut
- Paclitaxel and Trastuzumab and/or Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Conditions: Breast Cancer
Location: Manchester, Connecticut
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Middletown, Connecticut
- Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer
Location: Hartford, Connecticut
- Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Pa
Conditions: Diffuse Large B-cell Lymphoma
Location: Hartford, Connecticut
- Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
Conditions: Crohn's Disease
Location: Hartford, Connecticut
- Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
Conditions: Panic Disorder
Location: Hartford, Connecticut
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Hartford, Connecticut
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Hartford, Connecticut
- Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Hartford, Connecticut
- Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Conditions: Bladder Exstrophy
Location: Hartford, Connecticut
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Hartford, Connecticut
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Hartford, Connecticut
- Prospective Pediatric Pyeloplasty Robotic Surgical Database
Conditions: Hydronephrosis
Location: Hartford, Connecticut
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Hartford, Connecticut
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Norwich, Connecticut
- Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Hartford, Connecticut
- Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: New Britain, Connecticut
- Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy
Conditions: Tobacco Use Disorder
Location: Hartford, Connecticut
- Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer
Conditions: Impotence - Prostatic Neoplasms
Location: Hartford, Connecticut
- Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Conditions: Carcinoma of Unknown Primary
Location: Hartford, Connecticut
- Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Conditions: Kidney Cancer - Nonneoplastic Condition
Location: Hartford, Connecticut
- Safety and Efficacy of F2695 SR in Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Cromwell, Connecticut
- Home-Based Programs for Improving Sleep in Cancer Survivors
Conditions: Cancer Survivor - Fatigue - Psychosocial Effects of Cancer and Its Treatment - Sleep Disorders
Location: Hartford, Connecticut
- AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: New Britain, Connecticut
- Investigation of Naltrexone for Pathological Gambling
Conditions: Pathological Gambling
Location: Middletown, Connecticut
- Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Conditions: Sarcoma
Location: Farmington, Connecticut
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Manchester, Connecticut
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: New Britain, Connecticut
- I Change Adherence & Raise Expectations
Conditions: Cystic Fibrosis
Location: Hartford, Connecticut
- The Genetics of Severe Asthma in Children
Conditions: Asthma
Location: Hartford, Connecticut
- Assessing Response to Albuterol in Bronchiolitis
Conditions: Bronchiolitis
Location: Hartford, Connecticut
- Entereg Laparoscopic Colon Resection Study
Conditions: Laparoscopic Colonic Resection
Location: Hartford, Connecticut
- The Genetics of Respiratory Failure in Bronchiolitis
Conditions: Bronchiolitis
Location: Hartford, Connecticut
- Abstinence-Linked Money Management Multisite
Conditions: Mentally Ill Chemical Abuse - Cocaine Abuse - Cocaine Dependence - Polysubstance Abuse
Location: Hartford, Connecticut
- Benefits Management for People With Psychiatric Disabilities
Conditions: Mentally Ill Chemical Abuse - Schizophrenia - Bipolar Disorder
Location: Hartford, Connecticut
- Development of a Translational Tool to Study Yoga Therapy
Conditions: Health Behavior
Location: Storrs, Connecticut
- Prospective Pediatric Vesicoureteral Reflux Surgery Database
Conditions: Vesicoureteral Reflux
Location: Hartford, Connecticut
- Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Conditions: Ovarian Cancer
Location: New Britain, Connecticut
- Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neurob
Conditions: Neuroblastoma
Location: Hartford, Connecticut
- Insulin Resistance Intervention After Stroke Trial
Conditions: Stroke - Myocardial Infarction - Diabetes
Location: Hartford, Connecticut
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Conditions: Adrenocortical Carcinoma
Location: Hartford, Connecticut
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Norwich, Connecticut
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Norwich, Connecticut
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Hartford, Connecticut
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Hartford, Connecticut
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Middletown, Connecticut
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: New Britain, Connecticut
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Norwich, Connecticut
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroect
Conditions: Brain and Central Nervous System Tumors
Location: Hartford, Connecticut
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast - Breast Cancer
Location: Hartford, Connecticut
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast - Breast Cancer
Location: Manchester, Connecticut
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast - Breast Cancer
Location: Norwich, Connecticut
- Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone - Sarcoma
Location: Hartford, Connecticut
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: New London, Connecticut
- VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer
Conditions: Kidney Cancer
Location: Hartford, Connecticut
- VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer
Conditions: Kidney Cancer
Location: Manchester, Connecticut
- Interventional Management of Stroke (IMS) III Trial
Conditions: Acute Ischemic Stroke
Location: Hartford, Connecticut
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumor
Conditions: Kidney Cancer - Metastatic Cancer
Location: Hartford, Connecticut
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial
Conditions: Brain and Central Nervous System Tumors
Location: Hartford, Connecticut
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Hartford, Connecticut
- A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Conditions: Hepatitis B, Chronic
Location: Hartford, Connecticut
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Norwich, Connecticut
- Assessment and Tracking of Long-term Alefacept Safety
Conditions: Psoriasis
Location: Groton, Connecticut
- Assessment and Tracking of Long-term Alefacept Safety
Conditions: Psoriasis
Location: Groton, Connecticut
- Assessment and Tracking of Long-term Alefacept Safety
Conditions: Psoriasis
Location: Norwich, Connecticut
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Hartford, Connecticut
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Conditions: Endometrial Cancer
Location: Hartford, Connecticut
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Conditions: Endometrial Cancer
Location: New Britain, Connecticut
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Hartford, Connecticut
- IGIV Study for Chronic ITP Patients Ages 3-70
Conditions: Idiopathic Thrombocytopenic Purpura
Location: Hartford, Connecticut
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
Conditions: Retinoblastoma
Location: Hartford, Connecticut
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Middletown, Connecticut
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Norwich, Connecticut
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Norwich, Connecticut
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Hartford, Connecticut
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Manchester, Connecticut
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Norwich, Connecticut
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Farmington, Connecticut
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Hartford, Connecticut
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: New Britain, Connecticut
- Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Conditions: Neuroblastoma - Medulloblastoma
Location: Hartford, Connecticut
- Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators
Conditions: Death, Sudden, Cardiac - Myocardial Infarction - Arrhythmias, Cardiac
Location: Hartford, Connecticut
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Middletown, Connecticut
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Hartford, Connecticut
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: New Britain, Connecticut
- Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid
Conditions: Brain and Central Nervous System Tumors
Location: Hartford, Connecticut
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: New Britain, Connecticut
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Norwich, Connecticut
- Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)
Conditions: Heart Failure - Ventricular Dyssynchrony
Location: Hartford, Connecticut
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblasto
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Liver Cancer - Neuroblastoma - Ototoxicity - Ovarian Cancer - Sarcoma
Location: Hartford, Connecticut
- Healthy Activities for Prize Incentives
Conditions: Substance Abuse - HIV Infections
Location: Hartford, Connecticut
- Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine
Conditions: Mantle Cell Lymphoma
Location: Hartford, Connecticut
- Contingency Management Treatment Duration
Conditions: Alcohol Abuse
Location: Hartford, Connecticut
- Contingency Management Treatment Duration
Conditions: Alcohol Abuse
Location: New Britain, Connecticut
- Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: New Britain, Connecticut
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: New Britain, Connecticut
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Norwich, Connecticut
- Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
Conditions: Brain and Central Nervous System Tumors - Chemotherapeutic Agent Toxicity - Cognitive/Functional Effects - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment - Radiation Toxicity - Therapy-related Toxicity
Location: Hartford, Connecticut
- Juvenile Idiopathic Arthritis (JIA) Registry
Conditions: Juvenile Idiopathic Arthritis
Location: Hartford, Connecticut
- Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Conditions: Intraventricular Hemorrhage
Location: Hartford, Connecticut
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Conditions: Healthy
Location: West Hartford, Connecticut
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis - Venous Thrombosis - Postphlebitic Syndrome - Venous Thromboembolism - Post Thrombotic Syndrome
Location: Norwich, Connecticut
- Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
Conditions: Juvenile Idiopathic Arthritis
Location: Hartford, Connecticut
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Hartford, Connecticut
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: New Britain, Connecticut
- Validation of the Sickle Cell Disease Pain Burden Interview
Conditions: Sickle Cell Disease - Pain
Location: Hartford, Connecticut
- Study of NNZ-2566 in Patients With Traumatic Brain Injury
Conditions: Brain Injuries
Location: Hartford, Connecticut
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Farmington, Connecticut
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Hartford, Connecticut
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: New Britain, Connecticut
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Norwich, Connecticut
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Norwich, Connecticut
- A Phase 4, 6-Week, Randomized Double-Blind, Multicenter, Active-Controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood
Conditions: Arthritis, Juvenile Rheumatoid
Location: Hartford, Connecticut
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Hartford, Connecticut
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: Norwich, Connecticut
- Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry
Conditions: Inflammatory Bowel Disease
Location: Hartford, Connecticut
- Safety of Urate Elevation in Parkinson's Disease
Conditions: Parkinson Disease
Location: Manchester, Connecticut
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Hartford, Connecticut
- Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk
Conditions: Tobacco Use Cessation - Alcohol-related Disorders
Location: Newington, Connecticut
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Conditions: Breast Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Musculoskeletal Complications - Pain - Prostate Cancer - Urinary Complications
Location: Hartford, Connecticut
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Conditions: Breast Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Musculoskeletal Complications - Pain - Prostate Cancer - Urinary Complications
Location: Manchester, Connecticut
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Conditions: Breast Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Musculoskeletal Complications - Pain - Prostate Cancer - Urinary Complications
Location: Middletown, Connecticut
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Conditions: Breast Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Musculoskeletal Complications - Pain - Prostate Cancer - Urinary Complications
Location: New Britain, Connecticut
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Hartford, Connecticut
- Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
Conditions: Breast Cancer
Location: New Britain, Connecticut
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Perito
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Hartford, Connecticut
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Perito
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: New Britain, Connecticut
- Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Conditions: Cervical Cancer - Precancerous Condition
Location: New Britain, Connecticut
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Hartford, Connecticut
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: New Britain, Connecticut
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Hartford, Connecticut
- Study of Kidney Tumors in Young Patients
Conditions: Kidney Cancer - Nonneoplastic Condition
Location: Hartford, Connecticut
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Hartford, Connecticut
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: New Britain, Connecticut
- Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
Conditions: Sarcoma
Location: Hartford, Connecticut
- Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
Conditions: Sarcoma
Location: Hartford, Connecticut
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Hartford, Connecticut
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Conditions: Neuroblastoma
Location: Hartford, Connecticut
- Optical Tomography With Ultrasound Guidance
Conditions: Breast Cancer
Location: Hartford, Connecticut
- Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Tri
Conditions: B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Location: New Britain, Connecticut
- Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Hartford, Connecticut
- Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Conditions: Benign Prostatic Hyperplasia
Location: New Britain, Connecticut
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Conditions: Chordoma - Desmoid Tumor - Sarcoma
Location: Hartford, Connecticut
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Conditions: Brain and Central Nervous System Tumors
Location: Hartford, Connecticut
- Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
Conditions: Metastatic Cancer - Pain
Location: New Britain, Connecticut
- A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Andr
Conditions: Cancer - Cataract - Low Bone Mineral Density - Osteopenia - Osteoporosis - Prostate Cancer
Location: New Britain, Connecticut
- Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
Conditions: Prostate Cancer - Sexual Dysfunction and Infertility
Location: New Britain, Connecticut
- Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
Conditions: Bronchopulmonary Dysplasia
Location: Hartford, Connecticut
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastro
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
Location: Hartford, Connecticut
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Hartford, Connecticut
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Hartford, Connecticut
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Norwich, Connecticut
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: New Britain, Connecticut
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Norwich, Connecticut
- Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Hartford, Connecticut
- Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fall
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Hartford, Connecticut
- Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fall
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Hartford, Connecticut
- Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fall
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: New Britain, Connecticut
- Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fall
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Norwich, Connecticut
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Hartford, Connecticut
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Hartford, Connecticut
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: New Britain, Connecticut
- Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Hartford, Connecticut
- Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: New Britain, Connecticut
- Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Norwich, Connecticut
- Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Norwich, Connecticut
- Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Psychosocial Effects of Cancer and Its Treatment
Location: New Britain, Connecticut
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: Hartford, Connecticut
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Hartford, Connecticut
- Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patient
Conditions: Endometrial Cancer
Location: Hartford, Connecticut
|